Brief: CStone Pharmaceuticals Says Unit Will Sell CStone Ivosidenib Business To Les Laboratoires Servier For $50 Million
21/12/2023 09:05
Dec 21 (Reuters) - CStone Pharmaceuticals 2616.HK :
* UNIT WILL SELL CSTONE IVOSIDENIB BUSINESS TO LES
LABORATOIRES
SERVIER FOR $50 MILLION
* MAXIMUM GAIN DERIVED FROM TRANSACTION ESTIMATED TO BE
AROUND
US$39.5 MILLION ON AN UNAUDITED BASIS
Source text for Eikon: ID:
Further company coverage: 2616.HK
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on CStone Pharmaceuticals
See all newsBrief: CStone Pharmaceuticals Says CEO Purchases 496,000 Shares For Over HK$2.7 Million From Sept 17-22
Brief: CStone Pharmaceuticals Posts HY Loss Of Rmb252.3 Million
China's CStone Pharmaceuticals H1 revenue soars on drug sales
Brief: Cstone Pharmaceuticals Receives NMPA IND Approval For CS5007 In China
Brief: CStone Pharmaceuticals Says Directors And Senior Management Purchase 2.4 Million Shares In June 2026